Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study Article

fiu authors

publication date

  • January 1, 2004

keywords

  • ACTIVE METABOLITE
  • ADULTS
  • Clinical Neurology
  • EXPRESSION
  • HUMAN LIVER
  • INHIBITOR
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • SN-38
  • Science & Technology

Digital Object Identifier (DOI)

start page

  • 44

volume

  • 6

issue

  • 1